Yang Li | Biology and Life Sciences | Best Researcher Award

Published on by Forensic Scientist

Mrs. Yang Li | Biology and Life Sciences | Best Researcher Award

The First Affiliated Hospital of Kunming Medical University | China

Mrs. Yang Li is a committed attending doctor at the First Affiliated Hospital of Kunming Medical University, where she integrates clinical service with translational research. With a strong foundation in endocrinology and metabolic diseases, her academic and clinical endeavors focus on diabetic complications, particularly type 2 diabetic nephropathy. Her contributions to both provincial and national-level projects highlight her dedication to improving patient outcomes through evidence-based research.

Professional Profile

Scopus

Education

Mrs. Yang Li began her academic journey in clinical medicine at Tongji Medical College, one of China’s top-tier medical institutions. She specialized in endocrinology and metabolic diseases, laying a strong academic foundation in chronic disease management, hormonal regulation, and metabolic dysfunctions. Her education was marked by excellence in both theoretical understanding and hands-on training in hospital environments. Continuing her commitment to academic advancement, she is currently pursuing an academic master’s degree, with research embedded into her clinical role. Her educational path reflects a lifelong commitment to improving the diagnosis, treatment, and understanding of chronic metabolic disorders such as diabetes and its complications.

Experience

Mrs. Li’s professional experience encompasses extensive clinical practice, medical education, and rigorous scientific research. At the First Affiliated Hospital of Kunming Medical University, she functions both as a frontline clinician and a research investigator. Her clinical work has given her firsthand insight into the complexities of diabetic complications, particularly diabetic nephropathy. This experience fuels her research endeavors, allowing her to design studies that are both clinically relevant and methodologically sound. She has independently led two provincially funded research projects and participated in two nationally funded projects under the National Natural Science Foundation of China. Her dual role has equipped her with the skills to integrate clinical questions into laboratory settings and translate scientific findings back into patient care protocols.

Research Interest

Mrs. Li’s core research interests revolve around type 2 diabetic nephropathy, particularly the molecular mechanisms driving renal damage in diabetic patients. Her work investigates the interplay between metabolic stress, adipose tissue function, vascular endothelial integrity, and renal cellular injury. Of special interest is the role of perirenal adipose tissue in modulating the onset and progression of diabetic kidney disease, a relatively underexplored area that may yield novel diagnostic and therapeutic strategies. She is also interested in transcriptomics, signaling pathways such as TGF-β1, and the protective role of ACE2–Ang-(1-7)–Mas receptor axes in pancreatic and renal tissues. Through her research, she aims to uncover early biomarkers and develop targeted interventions that can prevent or slow the progression of diabetic nephropathy.

Award

Mrs. Yang Li is an exemplary nominee for the Best Researcher Award, a recognition that would honor her persistent and impactful contributions to clinical science. Her ability to lead government-funded projects, publish in respected international journals, and remain active in frontline patient care places her among the most promising early-career physician-researchers in China. The translational nature of her research directly addresses one of the world’s most pressing public health concerns: diabetes and its complications. Her leadership, scientific rigor, and commitment to evidence-based medicine make her a deserving recipient of this prestigious award.

Publications

Mrs. Yang Li has published four peer-reviewed articles in reputable SCI-indexed journals, reflecting her growing influence in the field of diabetic complications. Each of her publications contributes to a deeper understanding of the pathophysiological mechanisms behind diabetes and its impact on vital organs:

Title: Ang (1-7) protects islet endothelial cells from palmitate-induced apoptosis via AKT, eNOS, p38 MAPK, and JNK pathways
Journal: Journal of Diabetes Research
Published on: 2014
Citation: Cited by 64 articles

Title: The ACE2–Ang-(1-7)–Mas axis improves microvascular endothelial cell function in pancreatic β cells
Journal: International Journal of Molecular Medicine
Published on: 2014
Citation: Cited by 91 studies

Title: Scutellarin ameliorates diabetic nephropathy via the TGF-β1 signaling pathway
Journal: Natural Products and Bioprospecting
Published on: 2024
Citation: Cited by 6 articles

Title: Transcriptomic analysis of ceRNA regulatory networks in perirenal adipose tissue of T2DM SD rats with diabetic nephropathy
Journal: Biotechnology and Applied Biochemistry
Published on: 2025
Citation: Cited by 2 articles

Conclusion

Mrs. Yang Li exemplifies the integration of clinical excellence and scientific innovation. Her work has advanced the understanding of diabetic nephropathy at both cellular and systemic levels, contributing new insights into its prevention and treatment. By combining patient care with a robust research portfolio, she continues to bridge the gap between laboratory discovery and clinical application. Her academic background, research leadership, and impactful publications collectively highlight her qualifications for prestigious research recognition. With her contributions resonating across endocrinology and nephrology, Mrs. Yang Li stands as a valuable asset to the medical and scientific community.

Dan Wu | Agricultural and Biological Sciences | Best Researcher Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Dan Wu | Agricultural and Biological Sciences | Best Researcher Award

Jilin Agricultural University | China

Dr. Dan Wu serves as an Adjunct Professor and Ph.D. Supervisor at Jilin Agricultural University under the prestigious “Class A Talent Introduction Program”. With a strong background in biotechnology and peptide science, he is a dynamic academician committed to translational research. Dr. Wu is actively engaged in advancing bioactive peptide research and its applications in functional foods, with multiple industry collaborations and recognized publications to his credit.

Author Profile👤

Scopus

Strengths for the Awards✨

Dan Wu is a distinguished Adjunct Professor at Jilin Agricultural University and a PhD supervisor under the “Class A Talent Introduction Program.” His academic footprint includes over 10 SCI-indexed publications in top-tier journals (CAS Region I) as a first or corresponding author, indicating a consistent and high-impact research output.

He has also secured prestigious national and provincial research grants, such as the National Natural Science Foundation of China (Youth Fund) and other regional foundations. Notably, his industry collaborations have led to the successful commercialization of four bioactive peptide products, bridging academic research and real-world application. Additionally, he has served as a reviewer for high-impact journals like JAFC and FC and holds a nationally authorized patent. These combined achievements showcase his innovative research, leadership in academia, and industry relevance, all of which are key metrics for the Best Researcher Award.

🎓 Education

Dr. Dan Wu completed his doctoral studies in a specialized field related to bioactive peptides and food science, equipping him with the foundational expertise to lead cutting-edge research. His academic journey, marked by rigor and innovation, set the stage for his future roles as a supervisor and innovator in academia and industry.

💼 Experience

Dr. Wu has extensive experience in academic research, innovation, and supervision. He is a reviewer for top journals such as Journal of Agricultural and Food Chemistry (JAFC) and Food Chemistry (FC). As the chairperson for major scientific grants including the National Natural Science Foundation of China (Youth Fund), he has contributed significantly to project evaluation and development. He also collaborates with industry stakeholders, leading to successful product development and commercialization.

🔬 Research Interests On Agricultural and Biological Sciences

Dr. Wu’s primary research interests lie in the development, absorption, and metabolism of bioactive peptides, particularly those derived from ginseng and marine organisms. His investigations focus on functional foods, peptide delivery systems, and the biochemical mechanisms governing peptide absorption—aiming to bridge the gap between nutritional science and therapeutic applications.

🏆 Awards & Recognition

Dr. Wu was recognized under the “Class A Talent Introduction Program”, reflecting his exceptional academic capabilities. He received national authorization for a patent as the first inventor, and his works have significantly impacted both academia and industry. His ongoing contributions to journals and his leadership in grant-funded research further reinforce his stature in the scientific community.

📚 Publications

Dr. Wu has authored more than 10 SCI-indexed papers in leading journals from the Chinese Academy of Sciences (CAS) Region I, such as Food Chemistry, Journal of Functional Foods, and Journal of Agricultural and Food Chemistry. Here are sample publications:

  • Wu, D. Mechanism of intestinal paracellular absorption of shrimp peptide QMDDQ regulated by myosin light chain kinase, Food Chemistry, 2023, Cited by 23

  • Wu, D. Stability and bioavailability of ginseng-derived peptides in functional beverages, Journal of Functional Foods, 2022, Cited by 31

  • Wu, D. Peptide-enriched chlorella extracts and their bioactive potential, Journal of Agricultural and Food Chemistry, 2021, Cited by 40

🧪 Conclusion

Dr. Dan Wu exemplifies a blend of academic excellence, innovative research, and industry impact. Through his leadership in national research projects, high-impact publications, patented inventions, and successful product transformations, he has significantly contributed to advancing functional peptide applications in health and nutrition. His work not only enriches scientific understanding but also offers real-world benefits through commercialized bio-functional products.

Jie Huang | Biological Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Jie Huang | Biological Sciences | Best Researcher Award

University of Oxford | United Kingdom

Dr. Jie Huang (黄杰), is a distinguished plant biologist currently serving as a postdoctoral researcher at the Department of Biology, University of Oxford. His research focuses on molecular plant–pathogen interactions, alternative splicing, and effector biology. Dr. Huang has made substantial contributions to our understanding of how pathogens manipulate plant immune responses and has published widely in high-impact journals.

Professional profile👤

Google Scholar

Strengths for the Awards✨

1. Strong Academic Background & Training

  • PhD from Nanjing Agricultural University under a leading expert, Prof. Suomeng Dong.

  • Postdoctoral experience at the prestigious University of Oxford, a global hub for biological sciences.

2. Consistent and High-Impact Research Output

  • Multiple first-author and corresponding-author publications in top-tier journals such as Nature Communications, Advanced Science, The Plant Cell, Molecular Plant, and New Phytologist.

  • His research appears in elite plant biology and molecular journals, indicating significant peer recognition and impact.

3. Innovation in Research

  • Pioneered discoveries related to alternative splicing in plant immunity, plant-pathogen interactions, and protein-peptide interactions, a critical frontier in molecular plant pathology.

  • Integration of computational tools (AlphaFold-Multimer) in cross-kingdom interaction studies, reflecting interdisciplinary sophistication.

4. Competitive Funding Record

  • Secured prestigious funding from national (NSFC), provincial, and postdoctoral foundations in China as Principal Investigator, demonstrating independent scientific leadership.

5. International Collaboration & Mobility

  • Experience at institutions in China, the UK, and the USA, showcasing global integration and collaborative capacity.

  • Short-term training and collaborative publications with international partners, enhancing his scientific network and adaptability.

🎓 Education

 Dr. Huang began his academic journey with a Bachelor’s degree in Plant Science from Anhui Agricultural University (2009–2013). He then pursued his Ph.D. in Plant Pathology at Nanjing Agricultural University (2013–2018), where he was mentored by the esteemed Prof. Suomeng Dong. His doctoral research laid a strong foundation for his expertise in host–pathogen molecular dynamics.

🧪 Experience

 Following his Ph.D., Dr. Huang worked as a postdoctoral researcher at Nanjing Agricultural University (2018–2021), continuing under Prof. Dong’s supervision. In 2019, he broadened his global research exposure as a visiting scholar at Colorado State University with Prof. Anireddy Reddy. Since January 2022, he has been advancing his research at the University of Oxford under Prof. Renier A. L. van der Hoorn, contributing to frontier studies in plant proteomics and immunity.

🔬 Research Interests On Biological Sciences

🌿 Dr. Huang’s research delves into:

  • Alternative splicing in plant immunity

  • Effector biology in oomycete pathogens

  • Protease-targeting mechanisms at the plant–pathogen interface

  • Use of AlphaFold and other computational tools to predict protein interactions
    His work bridges molecular biology, bioinformatics, and biotechnology for improving crop resistance strategies.

🏆 Awards and Funding

 As a Principal Investigator, Dr. Huang has secured several prestigious research grants, including:

  • National Natural Science Foundation of China (No. 31901862)

  • Natural Science Foundation of Jiangsu Province (SBK2019040604)

  • Fundamental Research Funds for Central Universities (KYQN202009)

  • China Postdoctoral Science Foundation (2018M640494)

  • Special Postdoctoral Science Fund (2020T130306)

These awards reflect his scientific rigor and innovative research in plant molecular biology.

📚 Publications

1. A Phytophthora effector manipulates host histone acetylation and reprograms defense gene expression to promote infection
Authors: L Kong, X Qiu, J Kang, Y Wang, H Chen, J Huang, M Qiu, Y Zhao, G Kong, …
Year: 2017
Cited by: 144

2. An oomycete plant pathogen reprograms host pre-mRNA splicing to subvert immunity
Authors: J Huang, L Gu, Y Zhang, T Yan, G Kong, L Kong, B Guo, M Qiu, Y Wang, …
Year: 2017
Cited by: 120

3. Phytophthora effectors modulate genome-wide alternative splicing of host mRNAs to reprogram plant immunity
Authors: J Huang, X Lu, H Wu, Y Xie, Q Peng, L Gu, J Wu, Y Wang, ASN Reddy, …
Year: 2020
Cited by: 84

4. The Activation of Phytophthora Effector Avr3b by Plant Cyclophilin is Required for the Nudix Hydrolase Activity of Avr3b
Authors: G Kong, Y Zhao, M Jing, J Huang, J Yang, Y Xia, L Kong, W Ye, Q Xiong, …
Year: 2015
Cited by: 84

5. The Phytophthora sojae RXLR effector Avh238 destabilizes soybean Type2 GmACSs to suppress ethylene biosynthesis and promote infection
Authors: B Yang, Y Wang, B Guo, M Jing, H Zhou, Y Li, H Wang, J Huang, Y Wang, …
Year: 2019
Cited by: 71

6. AlphaFold-Multimer predicts cross-kingdom interactions at the plant-pathogen interface
Authors: F Homma, J Huang, RAL van der Hoorn
Year: 2023
Cited by: 69

7. Pathogen manipulation of chloroplast function triggers a light-dependent immune recognition
Authors: C Gao, H Xu, J Huang, B Sun, F Zhang, Z Savage, C Duggan, T Yan, …
Year: 2020
Cited by: 65

8. Cleavage of a pathogen apoplastic protein by plant subtilases activates host immunity
Authors: S Wang, R Xing, Y Wang, H Shu, S Fu, J Huang, JK Paulus, M Schuster, …
Year: 2021
Cited by: 40

9. Natural allelic variations provide insights into host adaptation of Phytophthora avirulence effector PsAvr3c
Authors: J Huang, L Chen, X Lu, Q Peng, Y Zhang, J Yang, BY Zhang, B Yang, …
Year: 2019
Cited by: 32

10. Phytophthora sojae apoplastic effector AEP1 mediates sugar uptake by mutarotation of extracellular aldose and is recognized as a MAMP
Authors: Y Xu, Y Zhang, J Zhu, Y Sun, B Guo, F Liu, J Huang, H Wang, S Dong, …
Year: 2021
Cited by: 31

📝 Conclusion

🌟 Dr. Jie Huang is a rising star in plant molecular biology, combining classical genetics, proteomics, and cutting-edge computational tools to unravel the complexities of plant immunity and pathogen virulence. His international collaborations, funding success, and impactful publications position him as a strong nominee for any prestigious research award recognizing scientific excellence in plant sciences.

Zhanbin Wang | Biological Sciences | Lifetime achievement Award

Published on by Forensic Scientist

Prof. Dr. Zhanbin Wang | Biological Sciences | Lifetime achievement Award

Northeast Forestry University | China

Dr. Wang Zhanbin is an Associate Professor in the College of Forestry at Northeast Forestry University, China. With over 25 years of experience in forest pathology, he is also the Director of the Forest Pathology Credit Committee of the Chinese Forestry Society. He is proficient in English and actively supervises master’s students while teaching courses like Integrated Management of Forest Pests. His extensive work focuses on plant disease resistance, forest pest management, and ecological sustainability.

Professional profile👤

Scopus

Strengths for the Awards✨

  1. Extensive Career Duration and Experience:
    With a professional journey spanning over three decades (from 1994 to present), Dr. Wang has consistently worked in the field of forest protection, particularly focusing on forest pathology and molecular biology of forest diseases.

  2. Significant Scientific Contributions:
    He has received multiple prestigious awards at provincial and national levels, including:

    • 1st Prize from Liaoning Provincial Forestry Department (2015),

    • Multiple 2nd and 3rd Prizes from the Heilongjiang Province Science and Technology Progress Awards,

    • Liangxi Forestry Science and Technology Award (twice).
      These awards reflect sustained and impactful contributions to applied forestry research, particularly in disease resistance in poplar and sustainable pest control.

  3. Academic Productivity:
    His work has been published in SCI-indexed journals and national agricultural bulletins. His recent research includes studies on microbial interactions, transcriptomics, and triterpenoid biosynthesis — showing both depth and evolution in research focus.

  4. Leadership and Social Service:
    Dr. Wang holds a leadership position as Director of the Forest Pathology Credit Committee of the Chinese Forestry Society, indicating strong recognition by the national academic community.

  5. Educational Contributions:
    He has trained Master’s students, taught specialized courses like Integrated Management of Forest Pests, and contributed to several important textbooks and national teaching materials — reinforcing his academic leadership.

  6. Interdisciplinary Application:
    His work bridges plant pathology, molecular biology, genetics, and environmental management, contributing to real-world forest sustainability and plant health.

🎓 Education

Dr. Wang holds a PhD in Forest Protection (2007) from Northeast Forestry University. He earned his Master’s in Genetic Engineering (2003) from Harbin Normal University and a Bachelor’s degree in Forest Protection (1994) from Northeast Forestry University. He furthered his research as a postdoctoral fellow (2009–2012) at Jilin Yanbian Forestry Group.

💼 Experience

  • 2005–Present: Associate Professor, College of Forestry, Northeast Forestry University

  • 2003–2005: Teaching Assistant, Northeast Forestry University

  • 1997–2003: Research Assistant, Institute of Microbiology, Heilongjiang Academy of Sciences
    Dr. Wang has consistently contributed to forest pathology, particularly in fungal disease resistance and pest management.

🔬 Research Interests On Biological Sciences

His key research areas include:

  • Forest Pathology

  • Molecular Biology of Forest Diseases

  • Transgenic Disease-Resistant Poplars

  • Integrated Pest and Disease Management in Coniferous-Broadleaf Forests
    He integrates lab-based molecular work with field-based ecological applications.

🏆 Awards

Dr. Wang has received numerous honors, including:

  • 2005: Third Prize, Chinese Forestry Society, for transgenic fungal resistance in poplar

  • 2010 & 2011: Heilongjiang Science & Technology Progress Awards

  • 2015: First Prize, Liaoning Provincial Forestry Department, for breeding stress-resistant poplar

  • 2017 & 2022: Liangxi Forestry Science & Technology Awards for disease control in artificial forests and ecological regulation techniques
    These awards underscore his innovation in forest biotechnology and sustainability.

📚 Publications

Below are Dr. Wang’s key peer-reviewed publications from recent years, including hyperlinks and citation contexts:

  1. 2023 – Effect of powdery mildew on interleaf microbial communities and leaf antioxidant enzyme systems, Journal of Forestry Research – cited by 2

  2. 2022 – Transcriptional Responses for Biosynthesis of Triterpenoids in Exogenous Inducers Treated Inonotus hispidus Using RNA-Seq, Molecules – cited by 3

  3. 2022 – Effects of Compound Elicitors on the Biosynthesis of Triterpenoids and Activity of Defense Enzymes from Inonotus hispidus, Molecules – cited by 1

  4. 2022 – The Powdery Mildew on Polygonum persicaria L.: Microscopic Observation and Phylogenetic Relationship Analysis, Chinese Agricultural Science Bulletin, 38(9):130–136

  5. 2022 – Isolation of Endophytic Fungi from Medicinal Plants and Screening and Identification of Antagonism, Chinese Agricultural Science Bulletin, 38(1):75–81

📖 He has also contributed to several academic books and national-level teaching materials on forest pathology and quarantine.

✅ Conclusion

Dr. Wang Zhanbin is a dedicated forest pathology expert whose innovations in disease-resistant poplars and integrated pest management have had a lasting impact on forestry research in China. His scholarly output, teaching excellence, and technological contributions make him a distinguished nominee for any scientific recognition in environmental and biological sciences.

Hamid Zaferani Arani | Biology | Best Researcher Award

Published on by Forensic Scientist

Dr. Hamid Zaferani Arani | Biology | Best Researcher Award

Department of Surgery, Shiraz University of Medical Sciences | Iran

Dr. Hamid Zaferani Arani is an accomplished Iranian Medical Doctor (M.D.) and President of the knowledge-based company Ideh Pardazan Teb Gostar. A prolific researcher in oncology, neuroscience, and regenerative medicine, he has authored numerous publications, books, and patents. Recognized as a top national medical student (2021), his work spans clinical studies, biomedical innovation, and medical education.

Professional profile👤

ORCID

Google Scholar

Scopus

Strengths for the Awards✨

  1. Extensive Research Output

    • Dr. Arani has a prolific publication record, with multiple peer-reviewed articles in reputable journals, including Plos One, Oxidative Medicine and Cellular Longevity, and Journal of Cancer Research and Therapeutics.

    • His research spans cancer biology, neuroscience, regenerative medicine, and clinical medicine, demonstrating multidisciplinary expertise.

  2. Academic and Professional Leadership

    • President of a knowledge-based medical equipment company, indicating applied research and innovation in medical technology.

    • Active involvement in research centers (Cognitive and Neuroscience Research Center, Cancer Research Center) and professional associations (Iran’s National Elites Foundation).

  3. Conference Participation and Recognition

    • Invited speaker and board member at multiple international and national conferences (e.g., LIMSC in the Netherlands, International Breast Cancer Congress).

    • Recipient of numerous awards, including “Distinctive Researcher” (2016-2021) and “Top Student in Medicine in Iran” (2021).

  4. Innovation and Patents

    • Holds multiple patents, including medical devices and therapeutic formulations (e.g., oral medicine for neonatal jaundice, hearing aid technology).

    • Demonstrates translational research impact, bridging laboratory findings with clinical and industrial applications.

Education 🎓

  • M.D. (2014–2021): Faculty of Medicine, Islamic Azad University, Tehran Medical Sciences.

  • Research Training: Cognitive Neuroscience (CNRC), Cancer Research Center (Shahid Beheshti University), and international workshops in Leiden, Netherlands (2017) on medical statistics, publishing, and innovation.

Experience 💼

  • President: Ideh Pardazan Teb Gostar (Dayan ATA MEDICA), leading R&D in medical equipment.

  • Researcher: Collaborated with Shahid Beheshti University on breast cancer studies (2016–2021).

  • Educator: Taught medical statistics, scientific writing, and research methodology at Islamic Azad University.

Research Interests On Biology 🔬

  • Cancer Biology: Biomarkers, breast cancer, and therapeutic agents (e.g., Hypericin, Naringenin).

  • Neuroscience: Cerebral ischemia, neuroprotection, and drug effects (e.g., FK506, Atorvastatin).

  • Regenerative Medicine: Scaffold engineering, wound healing, and amniotic membrane applications.

Awards & Honors 🏆

  • Top National Medical Student (2021)

  • Distinctive Researcher (2016–2020, Islamic Azad University)

  • Best Startup Idea (2019, ITEM Weekend)

  • Top Speaker at LIMSC (Leiden, 2017)

Publications 📜

  • Title: EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
    Authors: M Hashemi, HZ Arani, S Orouei, S Fallah, A Ghorbani, M Khaledabadi, …
    Year: 2022
    Citations: 115

  • Title: Hydrogels based on cellulose and its derivatives: applications, synthesis, and characteristics
    Authors: S Ghorbani, H Eyni, SR Bazaz, H Nazari, LS Asl, H Zaferani, V Kiani, …
    Year: 2018
    Citations: 60

  • Title: Verapamil Inhibits Mitochondria‐Induced Reactive Oxygen Species and Dependent Apoptosis Pathways in Cerebral Transient Global Ischemia/Reperfusion
    Authors: E Jangholi, ZN Sharifi, M Hoseinian, MR Zarrindast, HR Rahimi, A Mowla, …
    Year: 2020
    Citations: 44

  • Title: Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study
    Authors: H Zaferani Arani, G Dehghan Manshadi, HA Atashi, A Rezaei Nejad, …
    Year: 2021
    Citations: 30

  • Title: Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
    Authors: M Hashemi, HZ Arani, S Orouei, E Rostamnejad, A Ghorbani, …
    Year: 2022
    Citations: 21

  • Title: Cyanidin 3-glycoside induced apoptosis in MCF-7 breast cancer cell line
    Authors: SA Mirmalek, S Faraji, S Ranjbaran, H Aryan, HZ Arani, E Jangholi, …
    Year: 2020
    Citations: 15

  • Title: A comparative study on effective factors in patient safety culture from the nursing staff points of view
    Authors: K Alimohammadzadeh, S Esmaili Joladi, M Olya, A Ghaiyoomi, …
    Year: 2017
    Citations: 15

  • Title: Comparing the effects of oleoresin of Pistacia atlantica tree and diclofenac gel on the knee osteoarthritis improvement
    Authors: M Peivastegan, M Rajabi, HZ Arani, M Olya, HA Atashi, S Abolghasemi
    Year: 2020
    Citations: 12

  • Title: Knowledge, attitudes, and practices toward breast cancer: among midwives in a breast cancer educational seminar in Tehran
    Authors: HA Atashi, ME Vaghar, M Olya, P Mirzamohammadi, HZ Arani, …
    Year: 2020
    Citations: 9

  • Title: Effect of topical Areca palm L. hydroalcoholic extract on burn wound healing in rats
    Authors: Z Abbasy, AA Tameh, R Mozaffari-Kermani, HZ Arani, SA Talaei
    Year: 2021
    Citations: 7

Conclusion 🌟

Dr. Zaferani Arani exemplifies translational research, bridging clinical medicine with innovation. His leadership in knowledge-based enterprises, coupled with 50+ publications and 10+ patents, underscores his commitment to advancing healthcare. A dynamic educator and researcher, he continues to explore frontiers in cancer therapy, neuroprotection, and medical technology.